Sensorion SA (ALSEN.PA)
EUR 0.17
(-26.09%)
EUR 0.17
(-26.09%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.17 EUR | 41.38% |
| 2022 | -0.29 EUR | -52.63% |
| 2021 | -0.19 EUR | -26.67% |
| 2020 | -0.15 EUR | 76.92% |
| 2019 | -0.65 EUR | 39.81% |
| 2018 | -1.08 EUR | 19.4% |
| 2017 | -1.34 EUR | -22.94% |
| 2016 | -1.09 EUR | -9.0% |
| 2015 | -1.00 EUR | -6.38% |
| 2014 | -0.94 EUR | -88.0% |
| 2013 | -0.50 EUR | -66.67% |
| 2012 | -0.30 EUR | -100.0% |
| 2011 | -0.15 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.05 EUR | 0.0% |
| 2023 Q2 | -0.15 EUR | 0.0% |
| 2023 Q4 | -0.06 EUR | 0.0% |
| 2023 FY | - EUR | 41.38% |
| 2022 Q2 | -0.15 EUR | 0.0% |
| 2022 FY | - EUR | -52.63% |
| 2022 Q4 | -0.14 EUR | 0.0% |
| 2021 Q2 | -0.08 EUR | 0.0% |
| 2021 Q4 | -0.11 EUR | 0.0% |
| 2021 FY | - EUR | -26.67% |
| 2020 Q4 | -0.06 EUR | 0.0% |
| 2020 Q2 | -0.09 EUR | 0.0% |
| 2020 FY | - EUR | 76.92% |
| 2019 Q2 | -0.40 EUR | 0.0% |
| 2019 FY | - EUR | 39.81% |
| 2019 Q4 | -0.25 EUR | 0.0% |
| 2018 Q2 | -0.62 EUR | 0.0% |
| 2018 Q4 | -0.48 EUR | 0.0% |
| 2018 FY | - EUR | 19.4% |
| 2017 FY | - EUR | -22.94% |
| 2017 Q4 | -0.69 EUR | 0.0% |
| 2017 Q2 | -0.66 EUR | 0.0% |
| 2016 FY | - EUR | -9.0% |
| 2016 Q2 | -0.68 EUR | 0.0% |
| 2016 Q4 | -0.43 EUR | 0.0% |
| 2015 FY | - EUR | -6.38% |
| 2015 Q4 | -0.79 EUR | 0.0% |
| 2015 Q2 | -0.30 EUR | 0.0% |
| 2014 FY | - EUR | -88.0% |
| 2014 Q4 | -0.84 EUR | -250.0% |
| 2014 Q3 | -0.24 EUR | 76.47% |
| 2014 Q2 | -1.02 EUR | -325.0% |
| 2014 Q1 | -0.24 EUR | 0.0% |
| 2013 Q3 | -0.13 EUR | 0.0% |
| 2013 FY | - EUR | -66.67% |
| 2013 Q4 | -0.24 EUR | -84.62% |
| 2013 Q1 | -0.13 EUR | 0.0% |
| 2013 Q2 | -0.13 EUR | 0.0% |
| 2012 Q4 | -0.13 EUR | -71.96% |
| 2012 FY | - EUR | -100.0% |
| 2012 Q1 | -0.08 EUR | 0.0% |
| 2012 Q2 | -0.08 EUR | 0.0% |
| 2012 Q3 | -0.08 EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q4 | -0.08 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -41.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 95.044% |
| Adocia SA | -1.91 EUR | 91.099% |
| Aelis Farma SA | -0.39 EUR | 56.41% |
| Biophytis S.A. | -12.55 EUR | 98.645% |
| Advicenne S.A. | -0.67 EUR | 74.627% |
| genOway Société anonyme | 0.17 EUR | 200.0% |
| IntegraGen SA | -0.03 EUR | -556.371% |
| Medesis Pharma S.A. | -0.80 EUR | 78.75% |
| Neovacs S.A. | -0.00 EUR | -6700.0% |
| NFL Biosciences SA | -0.46 EUR | 63.043% |
| Plant Advanced Technologies SA | 0.07 EUR | 342.857% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -86.813% |
| Theranexus Société Anonyme | -0.88 EUR | 80.682% |
| TME Pharma N.V. | -1.34 EUR | 87.313% |
| Valbiotis SA | -0.59 EUR | 71.186% |
| TheraVet SA | -0.49 EUR | 65.306% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -13.333% |
| DBV Technologies S.A. | -0.71 EUR | 76.056% |
| Genfit S.A. | -0.58 EUR | 70.69% |
| GeNeuro SA | -0.59 EUR | 71.186% |
| Innate Pharma S.A. | -0.09 EUR | -80.659% |
| Inventiva S.A. | -2.43 EUR | 93.004% |
| MaaT Pharma SA | -1.73 EUR | 90.173% |
| MedinCell S.A. | -0.88 EUR | 80.682% |
| Nanobiotix S.A. | -1.08 EUR | 84.259% |
| OSE Immunotherapeutics SA | -1.18 EUR | 85.593% |
| Poxel S.A. | -0.91 EUR | 81.319% |
| GenSight Biologics S.A. | -0.54 EUR | 68.519% |
| Transgene SA | -0.22 EUR | 22.727% |
| Valneva SE | -0.73 EUR | 76.712% |